Lipid abnormalities during saquinavir soft-gel-based highly active antiretroviral therapy.
Moyle
G J
GJ
Baldwin
C
C
D000328:Adult; D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000009:adverse effects; D001786:Blood Glucose / Q000378:metabolism; D002784:Cholesterol / Q000097:blood*; D003430:Cross-Sectional Studies; D005260:Female; D005782:Gels; D015658:HIV Infections / Q000097:blood / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D008297:Male; D012016:Reference Values; D019258:Saquinavir / Q000008:administration & dosage / Q000009:adverse effects*; D014280:Triglycerides / Q000097:blood*
D019380:Anti-HIV Agents; D001786:Blood Glucose; D005782:Gels; D017320:HIV Protease Inhibitors; D014280:Triglycerides; D002784:Cholesterol; D019258:Saquinavir